Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 333

1.

Immunohistochemical detection of carcinoma in radical prostatectomy specimens following hormone therapy.

Kusumi T, Koie T, Tanaka M, Matsumoto K, Sato F, Kusumi A, Ohyama C, Kijima H.

Pathol Int. 2008 Nov;58(11):687-94. doi: 10.1111/j.1440-1827.2008.02294.x.

PMID:
18844933
2.

Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.

Chang SS, Reuter VE, Heston WD, Hutchinson B, Grauer LS, Gaudin PB.

Cancer. 2000 Jan 15;88(2):407-15.

PMID:
10640975
3.

P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.

Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG, Grignon DJ, Fanger GR, Amin MB.

Am J Surg Pathol. 2002 Dec;26(12):1588-96.

PMID:
12459625
5.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
6.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
7.

Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.

Suzue K, Montag AG, Tretiakova M, Yang XJ, Sahoo S.

Am J Clin Pathol. 2005 Apr;123(4):553-61.

8.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
9.

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.

Mazzucchelli R, Barbisan F, Tagliabracci A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R.

Virchows Arch. 2007 Apr;450(4):371-8. Epub 2007 Feb 7.

10.

Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.

Carswell BM, Woda BA, Wang X, Li C, Dresser K, Jiang Z.

Histopathology. 2006 May;48(6):668-73.

PMID:
16681682
11.

P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.

Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ.

Am J Surg Pathol. 2002 Sep;26(9):1169-74.

PMID:
12218573
12.
15.
16.
17.

Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.

Yang XJ, Laven B, Tretiakova M, Blute RD Jr, Woda BA, Steinberg GD, Jiang Z.

Urology. 2003 Aug;62(2):282-6.

PMID:
12893336
18.

An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.

Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC.

Am J Clin Pathol. 2004 Feb;121(2):220-5.

19.

Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.

Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z.

Am J Surg Pathol. 2002 Jul;26(7):921-5.

PMID:
12131160
20.

[Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas].

Xiao Y, Chen J, Luo YF, Cao JL, Ling Q, Jin F.

Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1362-6. Chinese.

PMID:
15387946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk